$CRWDNeutralLow

GANDHI SAMEER K sold $36K of CRWD

GANDHI SAMEER K sold 48 shares of CrowdStrike Holdings, Inc. (CRWD) at $750.76 on 2026-06-01 under a Rule 10b5-1 trading plan.

6/10
3/10
Low
Neutral
Filed June 3; transaction dated June 1.
Neutral—insider sale under 10b5-1 is usually not interpreted as a strong negative signal.

The filing is an insider sale disclosure; it may slightly affect near-term sentiment but does not signal a new fundamental catalyst by itself.

CrowdStrike director Sameer K. Gandhi sold 48 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Low likelihood of sustained price impact; any reaction is likely limited to short-term sentiment/positioning.

Background

The article reports a Form 4 insider transaction for CrowdStrike Holdings, Inc. (director role), including trade size, price, and 10b5-1 plan usage.

Why it matters

Because the sale is explicitly under a pre-arranged 10b5-1 plan and no new company-specific fundamentals are disclosed, the incremental trading signal is limited to sentiment/positioning rather than valuation repricing.

Market relevance

Insider sale disclosure for CRWD; likely low incremental impact versus any fundamental news.

Market effects

Minimal; this is company-specific insider activity without sector-wide read-through.

None indicated.

None indicated.

Alternative perspectives

Some traders may view repeated insider selling as a cautionary signal, even if executed via 10b5-1.

10b5-1 plans are pre-scheduled and can reflect diversification or liquidity needs rather than forward-looking views.

Key entities

  • CrowdStrike Holdings, Inc.

    Subject of the SEC Form 4 insider sale disclosure.

  • GANDHI SAMEER K

    Director who sold 48 shares at ~$750.76/share under a 10b5-1 plan.

Related articles

$CRWDMed

Weakness May Be an Opportunity for CrowdStrike Stock

CrowdStrike said demand for its Falcon platform and broader security offerings remains strong as cybersecurity spending grows, including amid AI adoption, according to management. The company raised full-year ARR guidance to $6.53B–$6.56B and increased revenue and earnings guidance. Analysts: 34 “Strong Buy,” 3 “Moderate Buy,” 11 “Hold,” 2 “Strong Sell” (consensus “Moderate Buy”); mean target $723.74 and high $825.

$ZSMedAI 9/10

Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure

Zscaler shares fell more than 31% after fiscal Q3 2026 results, despite revenue of $850M+ (+25% YoY vs. $835M est.) and adjusted EPS of $1.08 (+28% YoY vs. $1.01 est.). The company raised full-year revenue growth to 24.6%–24.7% but cut its free-cash-flow margin outlook (midpoint 26.75% to 23.1%) and guided 16%–17% ARR growth next year. CrowdStrike slipped about 7% after fiscal Q1 2027 beats and a raise; revenue was $1.39B (+26% YoY), EPS $1.10 (+51% YoY), and net new ARR growth guidance increase

$CRWDLow

Rosenblatt Lifts PT on CrowdStrike (CRWD) Following “Outstanding” Q1

Rosenblatt raised its CrowdStrike (CRWD) price target to $825 from $640 and kept a Buy rating after what it called an “outstanding” fiscal Q1. The firm said shares fell about 11% after hours, attributing it to profit taking after an ~87% post-earnings rise, and cited the “Mythos moment” and Falcon’s role in AI cybersecurity. Wedbush also raised its target to $720 from $700, maintaining Outperform.

$CRWDLow

Is CrowdStrike Stock a Buy on the Dip?

CrowdStrike shares fell after fiscal Q1 results, despite the company raising its full-year ARR growth outlook to 27%–29% from 23%–24%, according to the report. Ending ARR rose 24% to $5.51B and net new ARR 32% to $256M. Revenue grew 26% to $1.39B; adjusted EPS rose 51% to $1.10. Fiscal 2027 revenue guidance was $5.915B–$5.959B and adjusted EPS $4.88–$4.96.